ライフサイエンスコーパス: infant mortality

1 y result in increased maternal morbidity and infant mortality.

2 hereby decreasing the burden of maternal and infant mortality.

3 e SMN1 gene, is the leading genetic cause of infant mortality.

4 did not reduce all-cause maternal, fetal, or infant mortality.

5 ar atrophy (SMA), a leading genetic cause of infant mortality.

6 omalies are a leading cause of perinatal and infant mortality.

7 trophy (SMA) is the leading genetic cause of infant mortality.

8 and weakening the force of selection against infant mortality.

9 f low birth weight may have little effect on infant mortality.

10 gregation plays an independent role in black infant mortality.

11 hy (SMA) is the most common genetic cause of infant mortality.

12 workers is highly significant in explaining infant mortality.

13 disease that is the leading genetic cause of infant mortality.

14 ted forms of neurological disease leading to infant mortality.

15 tcomes but is not on the "causal" pathway to infant mortality.

16 e first 6 mo of life is critical to reducing infant mortality.

17 ate overall effects of prenatal variables on infant mortality.

18 and birth weight, and for the prevention of infant mortality.

19 Prematurity is one of the leading causes of infant mortality.

20 humans and the most common genetic cause of infant mortality.

21 iated with increased risks of stillbirth and infant mortality.

22 trophy (SMA) is the leading genetic cause of infant mortality.

23 ygen saturation homozygote, because of lower infant mortality.

24 ronutrient supplementation on fetal loss and infant mortality.

25 failed to reduce overall fetal loss or early infant mortality.

26 term births, which is a major contributor to infant mortality.

27 infertility, and reduce maternal, fetal, and infant mortality.

28 It is the most common genetic cause of infant mortality.

29 s and their odds ratios for transmission and infant mortality.

30 e were significant independent predictors of infant mortality.

31 ere iodine deficiency decreases neonatal and infant mortality.

32 s infection continues to be a major cause of infant mortality.

33 ation of the irrigation water would decrease infant mortality.

34 prenatal magnesium sulfate exposure on VLBW infant mortality.

35 us (HIV) type 1 contributes significantly to infant mortality.

36 ring pregnancy and lifetime and postneonatal infant mortality.

37 lifetime exposure to PM2.5 increases risk of infant mortality.

38 discharge explained the racial disparity in infant mortality.

39 ain the benefits of paid maternity leave for infant mortality.

40 obesity are risk factors for stillbirth and infant mortality.

41 r disease, is the leading monogenic cause of infant mortality.

42 birth defects and are a significant cause of infant mortality.

43 .96) for stillbirth and 1.29 (1.00-1.67) for infant mortality.

44 ar atrophy, the leading genetic disorder for infant mortality.

45 iginal hypothesis about OPV0 increasing male infant mortality.

46 ngenital anomalies are the leading causes of infant mortality.

47 ational age, Apgar scores, preterm birth, or infant mortality.

48 MA) is the most frequent cause of hereditary infant mortality.

49 sease that is the leading heritable cause of infant mortality.

50 a non-significant increase in perinatal and infant mortality.

51 th (OPV0) was associated with increased male infant mortality.

52 everity and the most common genetic cause of infant mortality.

53 s, with a reversal of this trend at very low infant mortality.

54 ntaneous preterm birth is a leading cause of infant mortality.

55 ons were associated with a high incidence of infant mortality (30.9%, 95% CI 2.4 to 5.4) and fetal wa

56 income, and key health indicators including infant mortality (43.0 vs 16.0 per 1000 nationwide) and

57 Infant mortality accounted for 48.1% of all mortality re

58 g cause of long-term neurologic handicap and infant mortality, accounting for 35% of all infant death

59 is one of the most common genetic causes of infant mortality across different races and is caused by

60 e prices, cigarette price differentials, and infant mortality across the European Union.

61 ween prenatal magnesium sulfate exposure and infant mortality (adjusted rate ratio, 1.02; 95% confide

62 The reduction in male excess infant mortality after 1970 can be attributed to improve

63 Infant mortality after invasive MRSA and MSSA infections

64 f stillbirth and neonatal, postneonatal, and infant mortality after the second pregnancy.

65 Infant mortality also differed significantly between the

66 ratively few studies evaluated particles and infant mortality, although infants and children are part

67 , the authors studied pregnancy outcomes and infant mortality among 202 married women in West Bengal,

68 l load, pregnancy outcomes, and maternal and infant mortality among 913 HIV-infected pregnant women.

69 opulations since Israel was founded in 1948, infant mortality among Arabs is still more than twice as

70 nded an intervention programme to reduce the infant mortality among Bedouin Arabs.

71 heart defects (CHD) are the leading cause of infant mortality among birth defects, and later morbidit

72 ial virus (RSV) is a global leading cause of infant mortality and adult morbidity.

73 Congenital anomalies are a leading cause of infant mortality and are important contributors to subse

74 design by estimating the association between infant mortality and birth weight in several regions of

75 ion (CVM), and it remains a leading cause of infant mortality and childhood morbidity.

76 Because of the increased infant mortality and developmental outcome associated wi

77 trophy (SMA) is the leading genetic cause of infant mortality and is caused by the loss of a function

78 atrophy is the most common genetic cause of infant mortality and is characterized by degeneration of

79 ry effect on the selected health indicators, infant mortality and life expectancy at birth.

80 rimarily birth weight) is a key predictor of infant mortality and morbidity and may serve as a predic

81 erm birth (PTB) contributes significantly to infant mortality and morbidity with lifelong impact.

82 Low birth weight is an important cause of infant mortality and morbidity worldwide.

83 UGR) still accounts for a large incidence of infant mortality and morbidity worldwide.

84 eterm delivery (PTD) is the leading cause of infant mortality and morbidity worldwide.

85 Preterm birth (PTB), a leading cause of infant mortality and morbidity, has a complex etiology w

86 a coli (EPEC) is responsible for significant infant mortality and morbidity, particularly in developi

87 ewborn (PPHN) is associated with substantial infant mortality and morbidity.

88 ina and India, the only countries where both infant mortality and overall under-five mortality were e

89 mes, including abortion, maternal mortality, infant mortality, and birth defects; leukemia; and Reye

90 utcome known to be associated with increased infant mortality, and it often results in a higher burde

91 e prevalences of HIV, tuberculosis, malaria, infant mortality, and maternal mortality.

92 modium falciparum is a major cause of global infant mortality, and no effective vaccine currently exi

93 increased rates of post-neonatal mortality, infant mortality, and under-5 mortality rates.

94 he variation in rates of maternal mortality, infant mortality, and under-five mortality across countr

95 Reductions in infant mortality associated with increases in the durati

96 We estimated the neonatal and infant mortality associated with these two characteristi

97 albendazole rose by 59 g (95% CI 19-98), and infant mortality at 6 months fell by 41% (RR 0.59; 95% C

98 Cumulative infant mortality at 7 months was significantly higher fo

99 Controlling for low birth weight, infant mortality, average income (socioeconomic status),

100 ight distribution has little or no effect on infant mortality, because the birth-weight-specific mort

101 it is the most frequently inherited cause of infant mortality, being the result of mutations in the s

102 genetic defects that lead to pregnancy loss, infant mortality, birth defects, and genetic diseases in

103 lly residents incurred the penalty of higher infant mortality, but as mortality rates fell at the end

104 mentation with 52 micromol vitamin A reduced infant mortality by 64%; acute side effects were limited

105 erweight/obesity and risks of stillbirth and infant mortality by including both population and sister

106 ue to differential changes in cause-specific infant mortality by sex.

107 MN supplements had an 18% reduction in early infant mortality compared with those of women given IFA

108 idence rate ratios (IRRs) for stillbirth and infant mortality, comparing exposed births to unexposed

109 ity, we carried out a study by analyzing the infant mortality data from the Shenyang Women and Childr

110 The primary outcome was early infant mortality (deaths until 90 days post partum).

111 he autonomous region during the same period, infant mortality declined from 64 to 59 per 1000 and und

112 sis of 15 developed countries shows that, as infant mortality declined over two centuries, the excess

113 ht, in this case maternal age, can influence infant mortality directly but not indirectly through bir

114 istribution and 2) maternal age also affects infant mortality directly, but 3) the influence of mater

115 ath data (2000-2010) to evaluate the risk of infant mortality due to external causes in multiples ver

116 ted controlled direct effect of plurality on infant mortality due to external causes was 1.64 (95% CI

117 gher-order multiples were at greater risk of infant mortality due to external causes, particularly be

118 ransition, with a reduction in childhood and infant mortality due to improved public health measures,

119 gnancy is associated with increased risks of infant mortality due to NEC in preterm babies, especiall

120 eight are associated with high perinatal and infant mortality, especially in developing countries.

121 tion, as compared with IFA, can reduce early infant mortality, especially in undernourished and anaem

122 Declines in infant mortality from infections and the shift of deaths

123 weaning, abrogating the benefit of reducing infant mortality from malaria.

124 A leading cause of infant mortality globally, its resurgence in several dev

125 In conclusion, infant mortality has been continuously decreased in Shen

126 Although infant mortality has improved in all subpopulations sinc

127 Preterm birth, a major determinant of infant mortality, has been increasing in recent years.

128 We investigated the effect of OPV0 on infant mortality in a randomized trial in Guinea-Bissau.

129 tment and maternal anaemia, birthweight, and infant mortality in a study of prenatal supplements, in

130 important factor in the national decrease in infant mortality in China.

131 xamined the impact on birth weight and early infant mortality in comparison with controls, who receiv

132 Preterm birth is the leading cause of infant mortality in developed countries, but the associa

133 a significant cause of diarrheal disease and infant mortality in developing countries.

134 ading cause of severe intestinal disease and infant mortality in developing countries.

135 ficant human pathogen and a leading cause of infant mortality in developing countries.

136 lobal significance and a major cause of high infant mortality in endemic nations.

137 Low birth weight (LBW) infants have lower infant mortality in groups in which LBW is most frequent

138 tating early-life interventions and reducing infant mortality in LMICs and warrant further discussion

139 tenatal vaccination could potentially reduce infant mortality in LMICs, broader gains at the populati

140 whether paid maternity leave policies affect infant mortality in LMICs.

141 pplements on stillbirth, birth outcomes, and infant mortality in low-income and middle-income countri

142 her efforts are still needed to decrease the infant mortality in rural areas.

143 Risks of infant mortality in second pregnancy only increased with

144 dium falciparum contributes significantly to infant mortality in sub-Saharan Africa and is associated

145 ant determinant of vertical transmission and infant mortality in subtype C infection in Zimbabwe.

146 The leading cause of infant mortality in the developing world is infectious d

147 ce differentials were associated with higher infant mortality in the European Union.

148 was associated with a 49% reduction in early infant mortality in the first 6 mo of life (RR: 0.51; 95

149 pregnancies affects risks of stillbirth and infant mortality in the second-born offspring.

150 anti-RSV Ab prophylaxis has greatly reduced infant mortality in the United States, there is currentl

151 ow-birth-weight infants, preterm births, and infant mortality in the United States.

152 ital heart defects remain a leading cause of infant mortality in the western world, despite decades o

153 a prevalent cause of traveler's diarrhea and infant mortality in third-world countries.

154 iated with increased risks of stillbirth and infant mortality independently of genetic and early envi

155 Infant mortality is 89.4/1000, and 12% of children die b

156 The strong association of birth weight with infant mortality is complicated by a paradoxical finding

157 red by kin after an infant death, so evolved infant mortality is lower.

158 Thus, evolved infant mortality is relatively high, more so in larger k

159 The leading genetic cause of infant mortality is spinal muscular atrophy (SMA), a cli

160 However, the US national policy for reducing infant mortality is to reduce low birth weight.

161 ike African elephants in zoos, this species' infant mortality is very high (for example, twice that s

162 besity and increased risks of stillbirth and infant mortality is well documented, but it has often be

163 rophy (SMA), the leading genetic disorder of infant mortality, is caused by low levels of survival mo

164 atrophy (SMA), the leading genetic cause of infant mortality, is caused by the loss of the survival

165 ron disease and the leading genetic cause of infant mortality; it results from loss-of-function mutat

166 mothers have a higher risk of NEC-associated infant mortality [light smoking: adjusted odds ratio (aO

167 me (SIDS), the leading cause of postneonatal infant mortality, likely comprises heterogeneous disorde

168 US Census were used in the denominator; for infant mortality, live birth counts were used.

169 ed for population, life expectancy at birth, infant mortality, low and high birthweight, maternal mor

170 Infant mortality, low birthweight, and placental malaria

171 Preterm birth is a leading cause of infant mortality, morbidity, and long-term disability, a

172 t effective means of preventing maternal and infant mortality/morbidity; however, influenza vaccinati

173 is, age-adjusted mortality (all causes), and infant mortality; more low-birth-weight infants; and hig

174 and functional outcomes such as neonatal and infant mortality; motor, cognitive, and emotional develo

175 risk of stillbirth or neonatal, 6-month, or infant mortality, neither overall or in any of the 26 ex

176 c mice survived probiotic colonization, some infant mortality occurred in beige-athymic pups born to

177 3-27 weeks of gestation) was associated with infant mortality (odds ratio, 288.1; 95% CI, 271.7-305.5

178 0 g/L) at enrolment had a reduction in early infant mortality of 25% (RR 0.75, 0.62-0.90, p=0.0021) a

179 Small babies from a population with higher infant mortality often have better survival than small b

180 n (OR = 1.01, 95% CI: 0.38, 2.70) or overall infant mortality (OR = 1.33, 95% CI: 0.43, 4.04).

181 female literacy (P = .01), as well as lower infant mortality (P = .007); however, no differences in

182 mortality rates for suicides (p < 0.001) and infant mortality (p = 0.003) increased during the crisis

183 and a 2.1-fold increase (95% CI, 1.3-3.5) in infant mortality (P<.01).

184 (400/mm3) were significantly associated with infant mortality (P=.035, Fisher's exact test).

185 New Zealand), I found that the sex ratio of infant mortality peaked in the 1970s or 1980s and declin

186 Outcomes were rates of all-cause infant mortality, postneonatal mortality, and external c

187 atrophy (SMA), the leading genetic cause of infant mortality, predominantly affects high metabolic t

188 quality was strongly associated with greater infant mortality (r=0.69, p=0.004 for women; r=0.74, p=0

189 rence greater than 1 year in 15 populations; infant mortality rate for 18 of 19 populations with a ra

190 The twin infant mortality rate for women with intensive prenatal

191 The very high infant mortality rate indicates a substantial need for r

192 The infant mortality rate is 38 per 1000 live births, with d

193 rtality rate is 54 per 1000 live births, the infant mortality rate is 46 per 1000 live births, and th

194 The early invitation with MMS group had an infant mortality rate of 16.8 per 1000 live births vs 44

195 e less likely to give birth and had a higher infant mortality rate than uninfected females.

196 Infant mortality rate was most strongly associated with

197 t in accounting for maternal mortality rate, infant mortality rate, and under-five mortality rate (wi

198 ssion analyses with maternal mortality rate, infant mortality rate, and under-five mortality rate as

199 nce of spontaneous abortions and the highest infant mortality rate.

200 prenatal care utilization also have a lower infant mortality rate.

201 996 and remained lower than the overall twin infant mortality rate.

202 tion were maternal, perinatal, neonatal, and infant mortality rates (MMR, PMR, NMR, and IMR, respecti

203 To compare the pattern of cause of death of infant mortality rates by urban/rural areas as well as t

204 ic situation, Albania has one of the highest infant mortality rates in Europe (45.4 per 1000 live bir

205 Maternity leave reduces neonatal and infant mortality rates in high-income countries.

206 ors do not fully explain the persistent high infant mortality rates of African Americans (blacks).

207 ntal factors associated with improvements in infant mortality rates over the last century explain the

208 o independent effect of segregation on black infant mortality rates was found.

209 in the early part of the 20th century, when infant mortality rates were high.

210 between prenatal smoking and NEC-associated infant mortality rates with adjustment for potential con

211 However, in countries with high infant mortality rates, low parity women had an increase

212 vidence, including the fact that, unlike for infant mortality rates, maternal mortality rates tended

213 Infant mortality rates, percent change, and annual perce

214 W) neonates (<2500 g at inclusion) to reduce infant mortality rates, we observed a very beneficial ef

215 vironmental circumstances, as indexed by low infant mortality rates, were relatively advantageous for

216 Annual infant mortality rates.

217 tion plays an independent role in high black infant mortality rates.

218 Infant-mortality rates decreased in the treated areas of

219 Setting the parameters (e.g. infant mortality, reduction of interbirth interval, life

220 er, disparities persisted; overall and among infants, mortality resulting from CHD was consistently h

221 xis was non-inferior to IPTp with respect to infant mortality (risk difference [RD] -0.05, 95% CI -0.

222 Infant mortality rose from 47 per 1000 live births durin

223 The infant mortality significantly decreased by 5.92%, 7.41%

224 en and young people aged 1-24 years, with UK infant mortality similar to the EU15+ median.

225 score at 5 min and the risk of neonatal and infant mortality, subdivided by specific causes.

226 to smokers had higher risks of both LBW and infant mortality than infants born to nonsmokers.

227 ed rates of spontaneous abortion and overall infant mortality that have been reported in some studies

228 micronutrients did not significantly reduce infant mortality; there were 764 deaths (54.0 per 1000 l

229 The primary outcome was all-cause infant mortality through 6 months (180 days).

230 women related to pregnancy, stillbirth, and infant mortality to 12 weeks (84 days) following pregnan

231 cid supplementation did not reduce all-cause infant mortality to age 6 months but resulted in a non-s

232 hy (SMA) is the most common genetic cause of infant mortality, typically resulting in death preceding

233 The male disadvantage in infant mortality underwent a surprising rise and fall in

234 rends in preterm birth rates on neonatal and infant mortality was also evaluated.

235 However, among LBW infants, infant mortality was lower for infants born to smokers (

236 Overall 1-year 5% infant mortality was similar to the 2%-4% post-neonatal

237 in Mali-a poorly resourced country with high infant mortality-was technically and logistically feasib

238 carotene groups the rates of stillbirth and infant mortality were 47.9 (95% CI, 44.3-51.5), 45.6 (95

239 bortion, stillbirth, neonatal mortality, and infant mortality were estimated with logistic regression

240 vertical transmission of subtype C HIV, and infant mortality were examined in 251 HIV-seropositive w

241 However, the risk of stillbirth and infant mortality when accounting for previous maternal p

242 nowledge gained about the black/white gap in infant mortality when national birth and infant death re

243 e women (BMI >/=30) had an increased risk of infant mortality when population controls were used (OR

244 th increasing sex ratios, except at very low infant mortality, where sex ratios decreased with total

245 igarette prices were associated with reduced infant mortality, while increased cigarette price differ

246 ) remains an important cause of maternal and infant mortality worldwide, including countries with mod

247 syncytial virus (RSV) is a leading cause of infant mortality worldwide.

248 iated with hypoketotic hypoglycemia and high infant mortality yet occurs at high frequency in Canadia